Veracyte reported $25.82M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Agilent USD 1.12B 28M Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bruker USD 1.12B 1.4M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Illumina USD 667M 38M Sep/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Laboratory Of America USD 538.4M 23.8M Sep/2026
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 11.69B 192M Sep/2026
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Veracyte USD 25.82M 3.16M Sep/2026
Waters USD 1.32B 53M Sep/2026